E
Eduardo Jaurrieta
Researcher at University of Barcelona
Publications - 156
Citations - 5936
Eduardo Jaurrieta is an academic researcher from University of Barcelona. The author has contributed to research in topics: Transplantation & Liver transplantation. The author has an hindex of 38, co-authored 156 publications receiving 5657 citations. Previous affiliations of Eduardo Jaurrieta include Bellvitge University Hospital.
Papers
More filters
Journal ArticleDOI
Biliary tract cancers (New England Journal of Medicine (Oct. 28 1999) 341 (1368-1378))
TL;DR: Alliance A011202 NCT01901094 A Randomized Phase III Trial Evaluating the Role of Axillary Lymph Node Dissection in Breast Cancer Patients (cT1-3N1) Who Have Positive Sentinel Lymph node Disease After Neoadjuvant Chemotherapy
Journal ArticleDOI
Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma : A comparative study
Juan Figueras,Eduardo Jaurrieta,Carlos Valls,C. Benasco,Antonio Rafecas,Xavier Xiol,Juan Fabregat,T. Casanovas,Jaime Torras,C. Baliellas,Luis Ibañez,Pablo Moreno,Luis Casais +12 more
TL;DR: Prognosis, recurrence rate, and survival after liver transplantation in patients in whom the main indication was HCC with cirrhosis were analyzed and results in cirrhotic patients with carefully selected HCC are similar to the results in Cirrhosis patients without tumor.
Journal ArticleDOI
Spanish Experience in Liver Transplantation for Hilar and Peripheral Cholangiocarcinoma
Ricardo Robles,Joan Figueras,Víctor Sánchez Turrión,Carlos Margarit,Angel Moya,Evaristo Varo,Javier Calleja,Andrés Valdivieso,Juan Carlos G. Valdecasas,Pedro García López,Manuel Gómez,Emilio Vicente,Carmelo Loinaz,Julio Santoyo,Manuel Fleitas,Angel Bernardos,Laura Lladó,Pablo Ramírez,Francisco Sánchez Bueno,Eduardo Jaurrieta,Pascual Parrilla +20 more
TL;DR: OLT for nondisseminated irresectable cholangiocarcinoma has higher survival rates at 3 and 5 years than palliative treatments, especially with tumors in their initial stages, which means that more information is needed to help better select cholangeous liver transplantation patients for transplantation.
Journal ArticleDOI
Resection or transplantation for hepatocellular carcinoma in cirrhotic patients: outcomes based on indicated treatment strategy.
Juan Figueras,Eduardo Jaurrieta,Carlos Valls,Emilio Ramos,Teresa Serrano,Antonio Rafecas,Juan Fabregat,Jaime Torras +7 more
TL;DR: In this paper, the authors analyzed the results of an orthotopic liver transplantation (OLT) for hepatocellular carcinoma (HCC) in patients with cirrhosis.
Journal ArticleDOI
Intraoperative red blood cell transfusion in liver Transplantation: Influence on patient outcome, prediction of requirements, and measures to reduce them
TL;DR: It is found the requirement of even a moderate number of blood transfusions is associated with longer hospital stay, and transfusion of more than six PRCUs are associated with diminished survival.